Summary of Workgroup Meeting on Use of Family History Information in Pediatric Primary Care and Public Health

A workgroup meeting on the use of family history information in pediatric primary care and public health sponsored by the National Center on Birth Defects and Developmental Disabilities at the Centers for Disease Control and Prevention was held February 24 to 25, 2006. The workgroup participants met to discuss how to improve the use of family history information in pediatric settings. Topics addressed at the meeting included current practices, needs, and barriers for use of family history information in pediatric primary care and public health. Other considerations included how available family history tools might be applicable to pediatric settings and which areas require additional research. Specific model conditions were presented that illustrated issues involved in the use of family history information in pediatric settings, including cystic fibrosis, fragile X syndrome, polycystic kidney disease, hyperlipidemia and coronary artery disease, and birth defects. Ethical, economic, and technologic concerns involved in integration of family history information into pediatric settings were discussed also.

[1]  Illiam,et al.  SCREENING OF INFANTS AND MORTALITY DUE TO NEUROBLASTOMA , 2022 .

[2]  D. Freedman,et al.  Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study. , 1986, The New England journal of medicine.

[3]  A. Folsom,et al.  Accuracy of proband reported family history: The NHLBI Family Heart Study (FHS) , 1999, Genetic epidemiology.

[4]  C. D. de Moor,et al.  Skin Cancer Prevention Counseling and Clinical Practices of Pediatricians , 2003, Pediatric dermatology.

[5]  N. Obuchowski,et al.  Occult intracranial aneurysms in polycystic kidney disease: screening with MR angiography. , 1994, Radiology.

[6]  Argyrios Ziogas,et al.  Validation of family history data in cancer family registries. , 2003, American journal of preventive medicine.

[7]  M. Province,et al.  Usefulness of cardiovascular family history data for population-based preventive medicine and medical research (the Health Family Tree Study and the NHLBI Family Heart Study). , 2001, The American journal of cardiology.

[8]  Muin J Khoury,et al.  Can family history be used as a tool for public health and preventive medicine? , 2002, Genetics in Medicine.

[9]  G. Forbes,et al.  Cranial computed tomography and magnetic resonance imaging in autosomal dominant polycystic kidney disease. , 1990, Journal of the American Society of Nephrology : JASN.

[10]  R W Sanson-Fisher,et al.  The accuracy of self-reported health behaviors and risk factors relating to cancer and cardiovascular disease in the general population: a critical review. , 1999, American journal of preventive medicine.

[11]  E. Levy,et al.  Usefulness of the American Academy of Pediatrics recommendations for identifying youths with hypercholesterolemia. , 2004, Pediatrics.

[12]  D. Wiebers,et al.  Value of magnetic resonance angiography for the detection of intracranial aneurysms in autosomal dominant polycystic kidney disease. , 1993, Journal of the American Society of Nephrology : JASN.

[13]  Gerald S. Berenson,et al.  Autopsy Studies in United States Children and Adolescents a , 1991 .

[14]  M. Rewers,et al.  Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). , 2004, The Journal of clinical endocrinology and metabolism.

[15]  G. Mensah,et al.  Serum Total Cholesterol Concentrations and Awareness, Treatment, and Control of Hypercholesterolemia Among US Adults: Findings From the National Health and Nutrition Examination Survey, 1999 to 2000 , 2003, Circulation.

[16]  Kakoli Roy,et al.  Measuring the Public's Health , 2006, Public health reports.

[17]  Dana C Crawford,et al.  FMR1 and the fragile X syndrome: Human genome epidemiology review , 2001, Genetics in Medicine.

[18]  Ncep Expert Panel on Blood Cholesterol Levels in Childr Adolescents National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. , 1992, Pediatrics.

[19]  Margaret Thorogood,et al.  Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia , 2002, BMJ : British Medical Journal.

[20]  J. Murray,et al.  Maternal interview reports of family history of birth defects: evaluation from a population-based case-control study of orofacial clefts. , 1997, American journal of medical genetics.

[21]  S. Andersen [Familial hypercholesterolemia in children]. , 1996, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[22]  M. Mennuti,et al.  Lights! Camera! Action! , 2001, Obstetrics and gynecology.

[23]  S. Sherman,et al.  Premature ovarian failure in the fragile X syndrome. , 2000, American journal of medical genetics.

[24]  R. Bennett The Practical Guide to the Genetic Family History , 1999 .

[25]  N. Stone,et al.  Management of lipids in clinical practice , 1997 .

[26]  J. Kastelein,et al.  Early statin therapy restores endothelial function in children with familial hypercholesterolemia. , 2002, Journal of the American College of Cardiology.

[27]  Asad A. Rizvi,et al.  Hypertrophic cardiomyopathy: Who plays and who sits , 2002, Current sports medicine reports.

[28]  Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. A preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. , 1990, JAMA.

[29]  D. Illingworth,et al.  Lipoproteins in Health and Diseases , 1999 .

[30]  M. Khoury,et al.  Quantifying the health benefits of genetic tests: The importance of a population perspective , 2006, Genetics in Medicine.

[31]  Muin J Khoury,et al.  Research priorities for evaluating family history in the prevention of common chronic diseases. , 2003, American journal of preventive medicine.

[32]  C. M. Sperberg-McQueen,et al.  Extensible Markup Language (XML) , 1997, World Wide Web J..

[33]  R. G. Walker,et al.  Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1 , 1994, The Lancet.

[34]  Ann M. Johnson,et al.  Attitudes of at-risk and affected individuals regarding presymptomatic testing for autosomal dominant polycystic kidney disease. , 1990, American journal of medical genetics.

[35]  Ann M. Johnson,et al.  Insurance for autosomal dominant polycystic kidney disease patients prior to end-stage renal disease. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  D. Bowen,et al.  Paternal relatives and family history of breast cancer. , 2006, American journal of preventive medicine.

[37]  T. Pearson,et al.  Challenges to implementing the current pediatric cholesterol screening guidelines into practice. , 1994, Pediatrics.

[38]  Ronald M. Lauer,et al.  National Cholesterol Education Program. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction: executive summary. National Heart, Lung and Blood Institute, National Institutes of Health. , 1991, Archives of internal medicine.

[39]  G. Berenson,et al.  Autopsy studies in United States children and adolescents. Relationship of risk factors to atherosclerotic lesions. , 1991, Annals of the New York Academy of Sciences.